Table 1.
Baseline sociodemographic and clinical characteristics of all patients participating in the RCTs and separately for those who have a valid baseline HRQoL form
| All Patients (n = 5287), n (%) | Patients Who Completed an HRQOL Form (n = 4307), n (%) | Patients Who Did Not Complete an HRQOL Baseline Form (n = 980), n (%) | P-value | |
|---|---|---|---|---|
| Male | 3191 (60) | 2659 (62) | 532 (54) | <0.001 |
| Female | 2096 (40) | 1648 (38) | 448 (46) | |
| Age (mean, SD) | 54 (14) | 54 (14) | 57 (13) | <0.001 |
| Gr II/III, A/O/OA | 1594 (30) | 1331 (31) | 263 (27) | 0.007 |
| Gr IV glioblastoma | 3693 (70) | 2976 (69) | 717 (73) | |
| WHO PS 0–1 | 4597 (87) | 3805 (88) | 792 (81) | 0.001 |
| WHO PS 2 | 659 (13) | 487 (11) | 172 (18) | |
| Missing | 31 (1) | 15 (0) | 16 (2) | |
| Biopsy | 985 (19) | 780 (18) | 205 (21) | 0.025 |
| Resection | 4287 (81) | 3514 (82) | 773 (79) | |
| Missing | 15 (0) | 13 (0) | 2 (0) | |
| 0 symptoms | - | 124 (3) | - | - |
| 1–4 concurrent symptoms | - | 1725 (40) | - | |
| 5–10 concurrent symptoms | - | 1896 (44) | - | |
| >10 concurrent symptoms | - | 562 (13) | - |
Gr, grade of the tumor; A, astrocytoma; O, oligondendroglioma; OA, oligoastrocytoma; SD, standard deviation.